We partnered with QME and WMAHSN to host a Lunch & Learn presented by MedCity on their exciting new joint investment call with Spex Capital.
Digital health and med-tech investment firm Spex Capital and London’s life sciences cluster organisation MedCity are now open for their first joint call as part of their exclusive partnership to identify and fund the next generation of digital health and medtech innovators.
Applications are invited from early-stage healthtech ventures with solutions to problems faced by healthcare systems globally. Interested companies will have six weeks to complete their applications for seed or series A rounds before the call closes at midnight on 12 November, 2021.
The call comes against the backdrop of the pandemic, which has accelerated the use of digital health solutions and diagnostics devices by consumers, fuelling an unprecedented boom in investment in the sector. Under the joint call, MedCity will use its extensive networks and expertise to attract and assess applications from investment-ready companies developing breakthrough digital health tech and medtech. Spex Capital will look to invest up to a max of £5 million per target company.
MedCity’s Programme Lead Sakura Holloway presented the what, why and how of this new investment opportunity at our online Lunch & Learn co-hosted by MedCity, QME and WMAHSN.
MedCity represents the life sciences cluster for London. They boost innovation and investment in the region, securing the UK’s position as a global science superpower.
Working in close partnership with London’s world-leading universities, MedCity connects private industry with partners in the NHS, charity sector and research institutes to catalyse exciting new opportunities that advance cutting-edge R&D in areas such as AI, diagnostics, and rare diseases. MedCity builds collaborations to accelerate uptake of medical innovation and growth across the UK. We help policymakers understand what life sciences requires to thrive in a competitive international landscape.
Queen Mary University Enterprise Zone (QME) is an innovation hub, offering flexible, modern workspace for Digital Health, MedTech and AI start-ups in East London. The centre creates the space and environment for start-ups to work, grow their venture, collaborate together and pioneer new exciting innovations. Members at the centre can enjoy many benefits including a dedicated community manager to help with any queries, fully serviced modern bright and spacious offices and breakout space, as well as access to training and workshops.
The West Midlands Academic Health Science Network (WMAHSN) is one of 15 AHSNs across England, established in 2013 with the vision to transform lives through innovation. We are working to improve the West Midland’s health and social care by supporting the development of innovation and giving patients access to the most effective medical discoveries. Working in collaboration with industry partners, universities, patients and more, the WMAHSN creates the right environment to improve the overall health and wealth of the region.
The WMAHSN deliver improvements to patient safety, enable the adoption and spread of approved, innovative solutions into the health & care system and power the development of innovation through our Innovation and Commercial service; our Meridian online Innovation Exchange, Serendip Incubator & Accelerator program, Health & Social Care Entrepreneur Academy, NHS Intellectual Property (IP) Service and the Industry Gateway.
If you’re a digitalhealth/medtech SME seeking investment, guidance on the application process and criteria for investability are outlined on the investment call web page here, along with the application portal.
If you have any questions for QME, WMAHSN, Health Foundry or MedCity specifically, don’t hesitate to contact us here. The call closes midnight on 12 November 2021.